Filgrastim biosimilar(Pooyesh Darou Pharmaceuticals)

非格司亭生物类似药（Pooyesh Darou Pharmaceuticals）

Report date: 2024/04/29 13:18:59

Base Information

Drug NameFilgrastim biosimilar(Pooyesh Darou Pharmaceuticals)

Drug Alias Name非格司亭生物仿制药（Pooyesh Darou Pharmaceuticals）Recombinant human granulocyte macrophage colony stimulating factor (Pooyesh Darou Pharmaceuticals)rhG-CSF (Pooyesh Darou Pharmaceuticals)重组人粒细胞刺激因子（Pooyesh Darou Pharmaceuticals）PD-grastim +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsFebrile NeutropeniaNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesPooyesh Darou

China Registration ClassN/A

Develop Information

Active CompaniesPooyesh Darou

Inactive CompaniesN/A

Active IndicationsFebrile NeutropeniaNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02